$24.31
+0.19 (+0.79%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+5.28%
1Y
+181.69%
YTD
+4.38%
Open$24.50
Previous Close$24.12
Day High$24.84
Day Low$23.80
52W High$28.72
52W Low$7.91
Volume—
Avg Volume1.31M
Market Cap3.06B
P/E Ratio—
EPS$-3.18
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$22.13
Above
SMA 200
$15.14
Above
RSI (14)
36.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+313.4% upside
Current
$24.31
$24.31
Target
$100.50
$100.50
$77.00
$100.50 avg
$121.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 295.45M | 226.99M | 841.86M |
| Net Income | -422,249,589 | -291,967,294 | -67,570,170 |
| Profit Margin | -142.9% | -135.8% | -8.0% |
| EBITDA | -449,754,650 | -328,262,843 | -58,220,570 |
| Free Cash Flow | — | — | -41,442,789 |
| Rev Growth | +30.2% | +30.2% | +8.2% |
| Debt/Equity | 0.16 | 0.16 | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |